The Toronto-based company earned $14 million, or 10 cents per share, compared with $47 million, or 33 cents per share, during the same period last year. Revenue rose 3 percent to $250 million from $242 million.
MDS' fiscal year ends Oct. 31.
During the quarter, the company took in $16 million from discontinued operations, compared with $33 million last year.
Shares of MDS fell 3 cents to $18.56 on the New York Stock Exchange in afternoon trading.